Arma Biosciences is commercializing a first-in-class sensing technology that represents the foundation for a new collection of portable, wearable, and implantable monitoring devices. The sensors are versatile and adaptable to the analysis of biomarkers for chronic disease, infectious disease, or personal wellness in biological fluids including blood, saliva, or urine. Requiring no reagents or complex fluidics, Arma’s sensor technology enables straightforward product development and scale-up. The initial product line will be for remote monitoring of biomarkers to manage chronic cardiovascular, renal, or metabolic diseases to prevent rehospitalizations and improve patient outcomes.